Wells Fargo & Company Cv Rx, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Cv Rx, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,894 shares of CVRX stock, worth $130,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,894

Previous 4,779 86.11%

Holding current value

$130,741

Previous $42,000 166.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$6.95 - $15.83 $28,599 - $65,140	4,115 Added 86.11%	8,894 $112,000
Q3 2024 Nov 13, 2024	SELL	$7.15 - $12.37 $1,158 - $2,003	-162 Reduced 3.28%	4,779 $42,000
Q2 2024 Aug 13, 2024	BUY	$6.49 - $19.2 $5,269 - $15,590	812 Added 19.67%	4,941 $59,000
Q1 2024 May 10, 2024	BUY	$17.99 - $30.49 $8,131 - $13,781	452 Added 12.29%	4,129 $75,000
Q4 2023 Feb 09, 2024	BUY	$11.67 - $33.01 $6,196 - $17,528	531 Added 16.88%	3,677 $115,000
Q3 2023 Nov 13, 2023	SELL	$13.56 - $18.47 $20,055 - $27,317	-1,479 Reduced 31.98%	3,146 $47,000
Q2 2023 Aug 15, 2023	BUY	$8.57 - $15.44 $38,667 - $69,665	4,512 Added 3992.92%	4,625 $71,000
Q1 2023 May 12, 2023	BUY	$7.08 - $19.4 $14 - $38	2 Added 1.8%	113 $1,000
Q4 2022 Feb 13, 2023	BUY	$8.94 - $18.35 $17 - $36	2 Added 1.83%	111 $2,000
Q3 2022 Nov 14, 2022	BUY	$6.12 - $9.5 $140 - $218	23 Added 26.74%	109 $1,000
Q2 2022 Aug 12, 2022	SELL	$4.7 - $7.22 $298,901 - $459,163	-63,596 Reduced 99.86%	86 $0
Q1 2022 May 16, 2022	BUY	$5.62 - $12.37 $4,805 - $10,576	855 Added 1.36%	63,682 $382,000
Q4 2021 Feb 14, 2022	SELL	$10.65 - $18.61 $2.65 Million - $4.62 Million	-248,370 Reduced 79.81%	62,827 $769,000
Q3 2021 Nov 15, 2021	SELL	$14.65 - $26.07 $704,108 - $1.25 Million	-48,062 Reduced 13.38%	311,197 $5.15 Million
Q2 2021 Aug 16, 2021	BUY	$28.0 - $28.0 $10.1 Million - $10.1 Million	359,259 New	359,259 $10.1 Million

Others Institutions Holding CVRX

# of Institutions

Shares Held

15.6M

Call Options Held

56.3K

Put Options Held

41.8K

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $302M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cv Rx, Inc. Transaction History